How Walbro is Assisting with the Fight Against COVID-19

 

Walbro Engineering Manager, New Product Development Brad Roche joins host Tyler Kern to outline how the company is doing its part to assist medical personnel on the front lines of the battle against the global COVID-19 pandemic.

On this episode of Talking Shop with Walbro, host Tyler Kern was joined by Walbro Engineering Manager, New Product Development Brad Roche for a special discussion about how the company is helping those on the front lines of the fight against the COVID-19 pandemic.

Walbro has created an aerosol shield for nurse anesthetists and anesthesiologists to utilize during intubation, which protects these front-line healthcare workers from aerosol particles potentially spreading the novel coronavirus.

The product addresses a critical need for personal protective equipment, or PPE, that has been exposed by the accelerated spread of the virus.

“Through some brainstorming that we did, we tried to identify a lot of things that we could help with, then we started reaching out to medical professionals,” Roche said. “Through their guidance and feedback, we’ve created this device, which is largely based on something people are building in their garages. We thought we could bring a level of professionalism to it and make it a lot more durable, a lot more usable and (make it) last a lot longer for medical professionals.”

The entire process of engaging in this transition to supporting the medical community took less two weeks, with the initial brainstorm coming in mid-March, further consultation and improvements aimed at mass production toward the end of the month, and the first prototype-tooled version finalized on March 27.

Though Walbro was able to convert a plant typically manufacturing products like fuel tanks into a viable location for the production of these shields, Roche said the real heroes are those serving our global community on the leading edge of the fight against COVID-19. Learn more today at https://www.walbro.com/aerosol-shield/.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More